Publication | Closed Access

Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, phase 2 trial

Gortec 2014-01 TpextremeNeoadjuvant TherapyMedicineCisplatin Versus PlatinumHead And Neck CancerCancer TreatmentNeck OncologyRadiation OncologyOncologyCancer TherapeuticsCancer ResearchMetastatic HeadRadiologyHealth Sciences